Vivos Therapeutics (VVOS) EBITDA Margin (2020 - 2026)
Vivos Therapeutics (VVOS) reported EBITDA Margin of -83.74% for Q2 2026, up 35.61 percentage points from -119.35% a year earlier and up 36.10 percentage points from the prior quarter.
Powered by 
Analysis
Vivos Therapeutics (VVOS) EBITDA Margin (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Vivos Therapeutics' EBITDA Margin came in at -99.35%, down 5.84 percentage points year-over-year; for FY2025, it came in at -106.55%, down 36.09 percentage points from FY2024.
- EBITDA Margin has a five-year change of -19.89 percentage points (FY2020 to FY2025).
- By year, EBITDA Margin came in at -70.45% in FY2024 (+50.37 pp), -120.82% in FY2023 (+31.21 pp), -152.03% in FY2022 (-35.66 pp) and -116.37% in FY2021 (-29.72 pp).
- Five-year quarterly EBITDA Margin spans a low of -181.06% in Q1 2022 and a high of -44.18% in Q2 2024.
- Year over year, EBITDA Margin gained in five of the last eight quarters, with an average year-over-year change of -5.50 percentage points.
- The high point for year-over-year EBITDA Margin in five years was Q2 2024 (a gain of 84.51 percentage points); the low point was Q1 2022 (a drop of 87.42 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -119.84% (Q1 2026), -155.33% (Q4 2025) and -64.13% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 249.71 Bn | 228.86 Bn | 4.88 Bn | 24.20% |
| 2 | Abbott Laboratories | 171.00 Bn | 142.08 Bn | 7.27 Bn | 21.86% |
| 3 | Danaher | 155.79 Bn | 139.61 Bn | 3.61 Bn | 28.51% |
| 4 | Intuitive Surgical | 143.91 Bn | 123.46 Bn | 1.96 Bn | 41.08% |
| 5 | Medtronic | 110.42 Bn | 76.29 Bn | 6.34 Bn | 25.55% |
| 6 | Stryker | 105.71 Bn | 91.82 Bn | 4.50 Bn | 29.67% |
| 7 | Boston Scientific | 63.26 Bn | 58.27 Bn | 3.85 Bn | 28.17% |
| 8 | Edwards Lifesciences | 49.80 Bn | 33.91 Bn | 1.35 Bn | 31.93% |
| 9 | Becton Dickinson | 48.78 Bn | 45.93 Bn | 2.32 Bn | 24.62% |
| 10 | Vivos Therapeutics | 2.18 Mn | -7.03 Mn | 2.95 Mn | -83.74% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -83.74% |
| Mar 31, 2026 | -119.84% |
| Dec 31, 2025 | -155.33% |
| Sep 30, 2025 | -64.13% |
| Jun 30, 2025 | -119.35% |
| Mar 31, 2025 | -124.04% |
| Dec 31, 2024 | -71.98% |
| Sep 30, 2024 | -64.74% |
| Jun 30, 2024 | -44.18% |
| Mar 31, 2024 | -106.43% |
| Dec 31, 2023 | -122.66% |
| Sep 30, 2023 | -105.76% |
| Jun 30, 2023 | -128.69% |
| Mar 31, 2023 | -125.23% |
| Dec 31, 2022 | -149.22% |
| Sep 30, 2022 | -123.20% |
| Jun 30, 2022 | -159.68% |
| Mar 31, 2022 | -181.06% |
| Dec 31, 2021 | -164.84% |
| Sep 30, 2021 | -116.82% |
API Access
Vivos Therapeutics EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=VVOS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "VVOS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=VVOS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();